SRPK2 and cancer: The observation that aberrant nuclear accumulation of SRPK2 has toxic effects on cancer cell proliferation and survival seems also to be overturned by the findings on LAM 621-101 cells that carry inactivating mutations in both alleles of the Tuberous Sclerosis Complex 2 (TSC2) gene (TSC2−/− cells).